Akay Bioactives Debuts FenuMat® PEA and FenuMat® Berberine at Vitafoods Europe
Akay Bioactives, a global leader in clinically backed botanical ingredients, will introduce two new ingredient innovations at Vitafoods Europe 2025: FenuMat PEA and FenuMat Berberine. These advanced solutions are powered by FenuMat, Akay’s patented, plant-based delivery technology that significantly enhances the bioavailability of natural actives.
FenuMat is a self-emulsifying hydrogel derived from fenugreek galactomannan, a soluble prebiotic dietary fibre. This plant-based matrix encapsulates bioactives to improve their solubility, stability, and controlled release without the use of synthetic emulsifiers or solvents. Backed by over 40 supporting scientific studies, FenuMat enables high bioactive loading at lower dosages and is suitable for a wide range of product formats including powders, capsules, gummies, and sachets.
FenuMat® PEA – enhanced joint and recovery support
FenuMat PEA is a proprietary formulation of palmitoylethanolamide (PEA), a plant-based compound derived from high-quality palm oil (Elaeis guineensis). As a naturally occurring lipid mediator, PEA supports the body's inflammatory response and is well-documented for its benefits to musculoskeletal and joint health, immunity, brain function, and recovery.
PEA has also been extensively researched for its role in neuroinflammation and chronic discomfort, making it especially relevant in formulations targeting long-term wellness and active aging.
Utilising FenuMat® technology, FenuMat® PEA offers: *
- 5.4x greater bioavailability
- 5x longer absorption peak
- 2.2x extended half-life
* In comparison to standard PEA materials
These improvements enable faster, longer-lasting delivery, making it ideal for managing joint stiffness, inflammation, and physical recovery.
FenuMat® Berberine – clean-label metabolic wellness
FenuMat Berberine is a proprietary complex extracted from Barberry root (Berberis aristata DC), designed to support metabolic health. Traditional berberine supplements are limited by rapid breakdown in the liver, reducing absorption into the bloodstream. Innovative FenuMat technology effectively enhances the absorption of ‘free’ berberine by 6x, in comparison to unformulated berberine extracts.
Berberine is well established for supporting:
- Cellular insulin sensitivity
- GLP-1 modulation
- Healthy blood glucose and lipid levels
Combined with diet and exercise, FenuMat Berberine is a powerful ally in supporting healthy weight and metabolic management. Consumer demand for berberine is growing rapidly, with the market experiencing an astounding 61.5% CAGR from 2022 to 2024.1 With continued growth expected through 2028, FenuMat Berberine is the next generation of berberine, poised to meet the needs of today’s informed and health-conscious consumer.
Visit Akay at Stand #3J250
These latest bioavailability-enhanced ingredients reflect Akay Bioactives’ ongoing commitment to harnessing the full power of nature for human health—meeting growing demand for sustainable, plant-based bioactives with superior bioavailability. Attendees of Vitafoods Europe 2025 can explore FenuMat PEA and FenuMat Berberine firsthand at stand #3J250 and discover Akay Bioactives’ full portfolio of clean-label, science-driven health solutions.
References
- Nutrition Business Journal Herbs and Botanicals Report, 2025. *These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Nothing on this page is meant to be perceived as an approved claim by EFSA.